Mahdi Behdani

7PUBLICATIONS
25CO-AUTHORS
BiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Vertebrate biologyGlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
Affinity enhancement of an anti-VEGF humanized nanobody as a superior candidate to bevacizumab: integrative in silico and in vitro studies.

|Feb 10, 2024
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic.

Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan

|Jan 26, 2024
CTXP, The Major Cobra Toxin Peptide from Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development.

Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh

|May 02, 2023
Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1.

Vahab Ziaei, Alireza Ghassempour, Fatemeh Davami

|Mar 11, 2023
Development and Characterization of a Novel Single-Chain Antibody Against B-Cell Activating Factor.

Rasoul Mardani-Jouneghani, Shiva Irani, Mahdi Habibi-Anbouhi

|Oct 06, 2022
In Vitro and In Vivo Studies of a Heminecrolysin Toxin-VEGF Fusion Protein as a Novel Therapeutic for Solid Tumor Targeting.

Zahra Naderiyan, Nazli Sotoudeh, Alireza Shoari

Pageof 2

Frequent Collaborators

2 joint publications

Mohammad Ali Shokrgozar

2 joint publications

Soheila Ajdary

2 joint publications

Reza Ahangari Cohan

1 joint publications

Vahab Ziaei